DSM net profit more than doubles in quarter

by Jeff Gelski
Share This:

HEERLEN, THE NETHERLANDS — Third-quarter net profit for DSM rose to €171 million ($234 million) from €79 million in the previous year’s third quarter. Net sales from continuing operations for the quarter ended Sept. 30 climbed 14% to €2,322 million ($3,190 million) from €2,041 million.

“We are pleased to have delivered continued profitable growth compared to last year across all business clusters,” said Feike Sijbesma, chief executive officer and chairman of Heerlen-based DSM, when third-quarter results were given Nov. 1. “This performance has been achieved despite the significant impact of a very strong Swiss franc and a weak U.S. dollar.”

On average, the Swiss franc was 13% stronger against the euro compared to the third quarter last year, according to the company. The U.S. dollar was 10% weaker compared to the third quarter last year.

DSM’s Nutrition cluster had third-quarter EBITDA of €176 million, up from €167 million in the previous year’s third quarter. Nutrition third-quarter sales of €868 million were up 16% from €751 million. Organic growth accounted for 8% of the growth. Recently acquired Martek Biosciences Corp. had sales of €84 million and EBITDA of €26 million in the third quarter. The weak U.S. dollar mainly caused a currency impact on sales of minus 2%.

Companywide, DSM’s net profit for the nine months ended Sept. 30 was €729 million, up from €358 million in the same time period of the previous year. Net sales for the nine-month period increased 12% to €6,821 million from €6,094 million.

Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.

The views expressed in the comments section of Food Business News do not reflect those of Food Business News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.